JSA Advises Biomapas Group on Strategic Acquisition of Pinnaxis

Transaction Overview

JSA advised clinical research and pharmacovigilance solutions provider Biomapas Group on its strategic acquisition of Indian regulatory operations entity Pinnaxis. The transaction enhances Biomapas' global clinical research footprint and extends its regulatory consulting reach across key emerging markets. JSA represented the acquirer through comprehensive legal due diligence, drafting and negotiation of the definitive acquisition agreements, and navigating Indian corporate and foreign direct investment compliances.